Illumina step up their healthcare plans with Lockheed Martin collaboration.

Illumina have progressed their plans to expand into healthcare by partnering with global security and aerospace company, Lockheed Martin. The collaboration will work on developing scalable and affordable genomics solutions.

As genomics begins to be introduced to national health systems, it is hoped that combining Illumina’s next-generation sequencing tools with Lockheed Martin’s expertise in large-scale information systems and integration will help make this transition more manageable.

“Genomics is enabling a fundamental transformation of health care,” said Horace Blackman, vice president of Health & Life Sciences for Lockheed Martin’s Information Systems & Global Solutions business. “We envision the advantages of early national adoption for countries across the globe, applying clinical decision support applications that can improve health and health care, and lower national health care costs.”

“We look forward to working with Lockheed Martin and global health care leaders as we develop best-in-class solutions to realize the full potential of nation-scale sequencing,” said Jay Flatley, Chief Executive Officer of Illumina. “We are excited about this collaboration, given the breadth and depth of Lockheed Martin’s operations and strategic relationships around the globe.”

Illumina’s press release can be read here. For a condensed analysis of Illumina’s recent activities, Zacks covered the story nicely from an stock market perspective.